Julien Blouin

Stock Analyst at Goldman Sachs

(2.13)
# 2,766
Out of 5,150 analysts
28
Total ratings
42.86%
Success rate
-0.41%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $37.75
Upside: -0.66%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $17.65
Upside: -3.68%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $310.97
Upside: +30.88%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $108.75
Upside: -2.53%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $30.03
Upside: +23.21%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $13.42
Upside: +49.03%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $31.03
Upside: +1.51%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.83
Upside: +60.27%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $15.08
Upside: +12.73%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $118.03
Upside: +22.85%
Initiates: Buy
Price Target: $176
Current: $141.74
Upside: +24.17%
Initiates: Neutral
Price Target: $318
Current: $256.07
Upside: +24.18%
Initiates: Neutral
Price Target: $81
Current: $62.78
Upside: +29.02%
Initiates: Buy
Price Target: $187
Current: $133.78
Upside: +39.78%